The Influence of Health Services Factor on the Maintenance of Leprosy Elimination Status at Community Health Centers in Timor-Leste
DOI:
https://doi.org/10.58344/jws.v5i3.1652Keywords:
Leprosy elimination, Health services, Health Policy, Human resosurces, Drug supplyAbstract
Introduction: Leprosy is a chronic disease caused by Mycobacterium leprae and manifests as damage to the skin and peripheral nerves. Globally, a total of 176,176 cases (0.2 cases per 10,000 population) were recorded for treatment at the end of 2015. Southeast Asia accounted for 72% of the global burden of new cases and 60% of global leprosy disabilities. Out of 14 countries globally reporting more than 1,000 cases annually, six are from the Southeast Asian Region. Method: This research is an epidemiological analytic study using a cross-sectional approach. The study population includes all managers and leprosy focal points from all Community Health Centers (CHCs) in Timor-Leste, with an estimated number of 136. Result: The findings of the study indicate that health policy, human resources, and drug supply influence leprosy elimination status, with the following results: 0.631 > 0.05, 0.569 > 0.05, and 0.396 > 0.05, respectively, from the perspective of CHC managers, and 0.384 > 0.05, 0.195 > 0.05, and 0.071 > 0.05 from the perspective of leprosy focal points. These results show that the hypothesis of no influence of health policy, human resources, and drug supply on the maintenance of leprosy elimination status was rejected. Conclusion: Based on the results outlined above, it can be concluded that health policy, human resources, and drug supply influence the status of leprosy elimination in Timor-Leste. Despite these results, this study also found that 53% of Community Health Centers in Timor-Leste are not properly implementing activities related to these three variables.
References
Bhat, R. M., & Prakash, C. (2012). Leprosy: An Overview of Pathophysiology. Interdisciplinary Perspectives on Infectious Diseases, 2012, 181089. https://doi.org/10.1155/2012/181089
Blok, D. J., de Vlas, S. J., Fischer, E. A. J., & Richardus, J. H. (2015). Mathematical Modelling of Leprosy and Its Control. Advances in Parasitology, 87, 33–51. https://doi.org/10.1016/bs.apar.2014.12.002
Dharmawan, Y., Fuady, A., Korfage, I. J., & Richardus, J. H. (2022). Delayed Detection of Leprosy Cases: A Systematic Review of Healthcare-Related Factors. PLOS Neglected Tropical Diseases, 16(4), e0010756. https://doi.org/10.1371/journal.pntd.0010756
Lockwood, D. N. J., & Saunderson, P. R. (2012). Nerve Damage in Leprosy: A Continuing Challenge to Scientists, Clinicians and Service Providers. International Health, 4(2), 77–85. https://doi.org/10.1016/j.inhe.2011.11.004
Martins-Melo, F. R., Lima, M. D. S., Ramos, A. N., Alencar, C. H., & Heukelbach, J. (2016). Mortality Related to Leprosy in Brazil: A Neglected Condition. PLOS Neglected Tropical Diseases, 10(3), e0004592. https://doi.org/10.1371/journal.pntd.0004592
Mieras, L., Anand, S., van Brakel, W., Burners, D., Butlin, C. R., Cavaliero, A., & Steinmann, P. (2016). Neglected Tropical Diseases and the Sustainable Development Goals: An Opportunity Not to Be Missed. Infectious Diseases of Poverty, 5, 43. https://doi.org/10.1186/s40249-016-0136-4
Notoatmodjo, S. (2011). Kesehatan Masyarakat Ilmu dan Seni (Edisi Revisi). Rineka Cipta.
Organization, W. H. (2016). Weekly Epidemiological Record: Global Leprosy Update 2015 (Issue 35). World Health Organization.
Reibel, F., Cambau, E., & Aubry, A. (2015). Update on the Epidemiology, Diagnosis, and Treatment of Leprosy. Médecine et Maladies Infectieuses, 45(9), 383–393. https://doi.org/10.1016/j.medmal.2015.09.002
Richardus, J. H., Tiwari, A., Barth-Jaeggi, T., Arif, M. A., Banstola, N. L., Blok, D. J., & Steinmann, P. (2021). Leprosy Post-Exposure Prophylaxis with Single-Dose Rifampicin (LPEP): An International Feasibility Programme. The Lancet Global Health, 9(1), e81–e90. https://doi.org/10.1016/S2214-109X(20)30396-X
Rodrigues, L. C., & Lockwood, D. N. J. (2011). Leprosy Now: Epidemiology, Progress, Challenges, and Research Gaps. The Lancet Infectious Diseases, 11(6), 464–470. https://doi.org/10.1016/S1473-3099(11)70006-8
Sandle, T. (2013). Global Strategies for Elimination of Leprosy: A Review of Current Progress. Journal of Infectious Diseases & Preventive Medicine, 1(4), 1–2. https://doi.org/10.4172/2329-8731.1000113
Schreuder, P. A. M., Noto, S., & Richardus, J. H. (2016). Epidemiologic Trends of Leprosy for the 21st Century. Clinics in Dermatology, 34(1), 24–31. https://doi.org/10.1016/j.clindermatol.2015.11.005
SEAR, W. H. O. (2009). Global Meeting of Leprosy Programme Managers on Leprosy Control Strategy, 20–22 April 2009. WHO Regional Office for South-East Asia.
SEAR, W. H. O. (2011). Guidelines for Strengthening Participation of Persons Affected by Leprosy in Leprosy Services. WHO Regional Office for South-East Asia.
SEAR, W. H. O. (2015). Evaluation of Implementation of Regional Flagship Areas in the WHO South-East Asia Region 2014–2018. WHO Regional Office for South-East Asia.
Sermrittirong, S., & van Brakel, W. H. (2014). Stigma in Leprosy: Concepts, Causes and Determinants. Leprosy Review, 85(1), 36–47.
Smith, W. C., van Brakel, W., Gillis, T., & Saunderson, P. (2015). The Missing Millions: A Threat to the Elimination of Leprosy. PLoS Neglected Tropical Diseases, 9(4), e0003658. https://doi.org/10.1371/journal.pntd.0003658
Steinmann, P., Cavaliero, A., Aerts, A., Anand, S., Arif, M., Bhattacharya, S. N., & Richardus, J. H. (2017). The Leprosy Post-Exposure Prophylaxis (LPEP) Programme: Study Protocol for Evaluating the Feasibility and Impact on Case Detection Rates of Contact Tracing and Single Dose Rifampicin. Infectious Diseases of Poverty, 6(1), 59. https://doi.org/10.1186/s40249-017-0273-5
Tiwari, A., & Richardus, J. H. (2016). Investment Case Concepts in Leprosy Elimination: A Systematic Review. Leprosy Review, 87(1), 2–22.
van Brakel, W. H., Sihombing, B., Djarir, H., Beise, K., Kusumawardhani, L., Yulihane, R., & Wilder-Smith, A. (2012). Disability in People Affected by Leprosy: The Role of Impairment, Activity, Social Participation, Stigma and Discrimination. Global Health Action, 5, 18394. https://doi.org/10.3402/gha.v5i0.18394
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 José Barreto, Nelson Eduardo Martins, Luis dos Reis
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International. that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
